ARIAD PHARMACEUTICALS INC's ticker is ARIA and the CUSIP is 04033A100. A total of 178 filers reported holding ARIAD PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 0.71 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $1,309,000 | -0.8% | 104,100 | +8.2% | 0.01% | -6.7% |
| Q3 2016 | $1,319,000 | +83.7% | 96,200 | 0.0% | 0.02% | +87.5% |
| Q2 2016 | $718,000 | +42.2% | 96,200 | +18.0% | 0.01% | +33.3% |
| Q1 2016 | $505,000 | -17.1% | 81,500 | -15.1% | 0.01% | -14.3% |
| Q4 2015 | $609,000 | +9.7% | 96,000 | +1.1% | 0.01% | 0.0% |
| Q3 2015 | $555,000 | -26.3% | 95,000 | +4.4% | 0.01% | -22.2% |
| Q2 2015 | $753,000 | +3.9% | 91,000 | +3.4% | 0.01% | 0.0% |
| Q1 2015 | $725,000 | +6.3% | 88,000 | -12.0% | 0.01% | 0.0% |
| Q4 2014 | $682,000 | +15.4% | 100,000 | -8.7% | 0.01% | +12.5% |
| Q3 2014 | $591,000 | -13.3% | 109,500 | +2.3% | 0.01% | -20.0% |
| Q2 2014 | $682,000 | -23.5% | 107,000 | -3.2% | 0.01% | -28.6% |
| Q1 2014 | $891,000 | +28.9% | 110,500 | +4.7% | 0.01% | +27.3% |
| Q4 2013 | $691,000 | -63.6% | 105,500 | +2.2% | 0.01% | -66.7% |
| Q3 2013 | $1,899,000 | – | 103,200 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 12,850,000 | $69,390,000 | 26.80% |
| Opaleye Management Inc. | 1,500,000 | $8,100,000,000 | 6.31% |
| Camber Capital Management LP | 6,000,000 | $32,400,000 | 3.04% |
| Ghost Tree Capital, LLC | 700,000 | $3,780,000 | 2.05% |
| Granite Point Capital Management, L.P. | 700,000 | $3,780,000 | 1.88% |
| Duquesne Family Office | 1,645,000 | $8,883,000 | 1.09% |
| Geduld E E | 272,200 | $1,470,000 | 1.04% |
| Elk Creek Partners, LLC | 659,232 | $3,560,000 | 0.93% |
| Palo Alto Investors LP | 2,231,717 | $12,051,000 | 0.90% |
| HighVista Strategies LLC | 1,200,000 | $6,480,000 | 0.87% |